2026 Meeting Overview
Save the date for the ASCCP 2026 Annual Scientific Meeting!
Taking place at the Renaissance Orlando at SeaWorld®, April 23-25 2026. The 2026 ASCCP Annual Scientific Meeting will spotlight the intersection of cutting-edge technology and clinical practice, with a focus on artificial intelligence, digital innovation, and implementation science. Join us as we explore how these tools are reshaping the future of cervical cancer prevention, diagnostics, and care delivery.
Includes:
- Cutting-edge research presentations
- Clinical guideline updates
- Networking with leading experts
- CME-accredited sessions on the latest advancements
Who should attend:
All healthcare professionals interested in evidence-based cervical cancer screening, prevention, and treatment. Whether you’re a seasoned expert or just starting your career, there’s something for everyone at this event.
Leadership

Michelle J. Khan, MD, MPH
ASCCP President 2025-2026
Michelle Khan is a Clinical Professor at Stanford University School of Medicine. She is a board-certified obstetrician gynecologist with training in Reproductive Infectious Diseases. She sees patients for obstetrics at Lucille Packard Children’s Hospital and for gynecology and dysplasia at Stanford Health Care. She works as a generalist seeing patients for routine Ob/Gyn care, pregnancy and delivery, and in subspecialty clinics focused on HPV-related diseases of the anogenital tract. She sees patients of any gender.
Dr. Khan’s clinical expertise is in screening, evaluation and treatment of HPV-related diseases and prevention of HPV-related cancers. She started working in the HPV field in 2003 during a Howard Hughes-National Institutes of Health research fellowship. She completed medical school at Rutgers University – Robert Wood Johnson Medical School, residency in Gynecology/Obstetrics at the Johns Hopkins Hospital, and fellowship in Reproductive Infectious Diseases at the University of California San Francisco. During fellowship she was trained in advanced colposcopy, high-resolution anoscopy (HRA) and treatment of cervical, vulvar, vaginal and anal disease. She is active in professional societies teaching national and international courses in colposcopy and HRA and formulating guidelines for screening and management of HPV-related diseases. She is the President of the ASCCP and the Secretary of the International Anal Neoplasia Society.

Christine Conageski, MD, MSc
ASCCP President-Elect 2025-2026
Christine Conageski, MD is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine. She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.
Program Co-Chairs

Christine Conageski, MD, MSc
Co-Chair
Christine Conageski, MD is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine. She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.

Lindsay Kuroki, MD, MSCI
Co-Chair
Dr. Lindsay Kuroki is an Associate Professor in the Department of Obstetrics and Gynecology at WashU Medicine in St. Louis. As a board-certified, clinically active gynecologic oncologist with expertise in cancer prevention and control, her current work focuses on designing innovative strategies to improve earlier detection of gynecologic cancers; and addressing the social determinants of health that strongly influence whether patients gain equitable access to care and treatment options. Dr. Kuroki has received grant funding from the NIH/NCI, AAOGF, Doris Duke Foundation, and has over 70 publications in peer-reviewed journals.

Lisa Gabor, MD
Co-Chair
Lisa Gabor is an assistant professor and attending physician in gynecologic oncology at Rutgers – New Jersey Medical School. Within ASCCP, she has previously served as a Junior Board Member and currently sits on the Program Committee.
Attend 2026 ASCCP Scientific Meeting
Don’t miss an immersive experience with insightful presentations and engaging discussions.
Trainee Research Award Application
ASCCP is offering an award to junior investigators for research in anogenital and HPV-related diseases, with recipients presenting their work at the 2027 Annual Scientific Meeting
Upcoming ASCCP Meetings
2026
Orlando, FL
April 23-25
2027
Chicago, IL
April 15-17
2028
Portland, OR
April 27-29
2029
Louisville, KY
April 12-14
